Publications en collaboration avec des chercheurs de Hospital Ramón y Cajal (12)

2024

  1. Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease

    International Journal of Biological Sciences, Vol. 20, Núm. 14, pp. 5608-5672

2022

  1. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity

    Biomedicines, Vol. 10, Núm. 3

  2. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

    Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453

  3. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer

    Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459

  4. Towards the Search for Potential Biomarkers in Osteosarcoma: State-of-the-Art and Translational Expectations

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2021

  1. Aging in Male Wistar Rats Associates with Changes in Intestinal Microbiota, Gut Structure, and Cholecystokinin-Mediated Gut-Brain Axis Function

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 76, Núm. 11, pp. 1915-1921

  2. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)

    Oncology Letters, Vol. 22, Núm. 5

2020

  1. Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease

    European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596

2019

  1. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease

    Therapeutic Advances in Gastroenterology, Vol. 12

2016

  1. Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximab

    Biochemical Pharmacology, Vol. 122, pp. 33-41

2009

  1. RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-α-induced cell death in hepatocarcinoma cancer cell lines

    Journal of Cellular Biochemistry, Vol. 108, Núm. 6, pp. 1292-1301

1999

  1. Expression, pharmacological, and functional evidence for PACAP/VIP receptors in human lung

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 277, Núm. 1 21-1